215 related articles for article (PubMed ID: 16908801)
1. Low serum testosterone and mortality in male veterans.
Shores MM; Matsumoto AM; Sloan KL; Kivlahan DR
Arch Intern Med; 2006 Aug 14-28; 166(15):1660-5. PubMed ID: 16908801
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of diagnosed depressive illness in hypogonadal older men.
Shores MM; Sloan KL; Matsumoto AM; Moceri VM; Felker B; Kivlahan DR
Arch Gen Psychiatry; 2004 Feb; 61(2):162-7. PubMed ID: 14757592
[TBL] [Abstract][Full Text] [Related]
3. Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit.
Shores MM; Moceri VM; Gruenewald DA; Brodkin KI; Matsumoto AM; Kivlahan DR
J Am Geriatr Soc; 2004 Dec; 52(12):2077-81. PubMed ID: 15571546
[TBL] [Abstract][Full Text] [Related]
4. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study.
Amin S; Zhang Y; Felson DT; Sawin CT; Hannan MT; Wilson PW; Kiel DP
Am J Med; 2006 May; 119(5):426-33. PubMed ID: 16651055
[TBL] [Abstract][Full Text] [Related]
5. Hormonal predictors of prostate cancer.
Sofikerim M; Eskicorapci S; Oruç O; Ozen H
Urol Int; 2007; 79(1):13-8. PubMed ID: 17627161
[TBL] [Abstract][Full Text] [Related]
6. Testosterone treatment and mortality in men with low testosterone levels.
Shores MM; Smith NL; Forsberg CW; Anawalt BD; Matsumoto AM
J Clin Endocrinol Metab; 2012 Jun; 97(6):2050-8. PubMed ID: 22496507
[TBL] [Abstract][Full Text] [Related]
7. Prostate-cancer-specific survival and clinical progression-free survival in men with prostate cancer treated intermittently with testosterone-inactivating pharmaceuticals.
Scholz M; Lam R; Strum S; Jennrich R; Johnson H; Trilling T
Urology; 2007 Sep; 70(3):506-10. PubMed ID: 17905106
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
Morgentaler A; Rhoden EL
Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of androgen deficiency in men with erectile dysfunction.
Köhler TS; Kim J; Feia K; Bodie J; Johnson N; Makhlouf A; Monga M
Urology; 2008 Apr; 71(4):693-7. PubMed ID: 18313109
[TBL] [Abstract][Full Text] [Related]
10. Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men.
Friedrich N; Schneider HJ; Haring R; Nauck M; Völzke H; Kroemer HK; Dörr M; Klotsche J; Jung-Sievers C; Pittrow D; Lehnert H; März W; Pieper L; Wittchen HU; Wallaschofski H; Stalla GK
Steroids; 2012 Jan; 77(1-2):52-8. PubMed ID: 22037276
[TBL] [Abstract][Full Text] [Related]
11. Serum testosterone and the risk of prostate cancer: potential implications for testosterone therapy.
Parsons JK; Carter HB; Platz EA; Wright EJ; Landis P; Metter EJ
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2257-60. PubMed ID: 16172240
[TBL] [Abstract][Full Text] [Related]
12. Low testosterone and anaemia in men with type 2 diabetes.
Grossmann M; Panagiotopolous S; Sharpe K; MacIsaac RJ; Clarke S; Zajac JD; Jerums G; Thomas MC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):547-53. PubMed ID: 18702678
[TBL] [Abstract][Full Text] [Related]
13. Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study.
Meier C; Nguyen TV; Handelsman DJ; Schindler C; Kushnir MM; Rockwood AL; Meikle AW; Center JR; Eisman JA; Seibel MJ
Arch Intern Med; 2008 Jan; 168(1):47-54. PubMed ID: 18195195
[TBL] [Abstract][Full Text] [Related]
14. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men--the MINOS study.
Szulc P; Claustrat B; Delmas PD
Clin Endocrinol (Oxf); 2009 Oct; 71(4):594-602. PubMed ID: 19207314
[TBL] [Abstract][Full Text] [Related]
16. Endogenous testosterone levels, physical performance, and fall risk in older men.
Orwoll E; Lambert LC; Marshall LM; Blank J; Barrett-Connor E; Cauley J; Ensrud K; Cummings SR;
Arch Intern Med; 2006 Oct; 166(19):2124-31. PubMed ID: 17060543
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
19. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men.
Chu LW; Tam S; Lee PW; Wong RL; Yik PY; Tsui W; Song Y; Cheung BM; Morley JE; Lam KS
Clin Endocrinol (Oxf); 2008 Apr; 68(4):589-98. PubMed ID: 17973937
[TBL] [Abstract][Full Text] [Related]
20. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality.
Krewski D; Jerrett M; Burnett RT; Ma R; Hughes E; Shi Y; Turner MC; Pope CA; Thurston G; Calle EE; Thun MJ; Beckerman B; DeLuca P; Finkelstein N; Ito K; Moore DK; Newbold KB; Ramsay T; Ross Z; Shin H; Tempalski B
Res Rep Health Eff Inst; 2009 May; (140):5-114; discussion 115-36. PubMed ID: 19627030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
